Deficiency of CCR1 impaired the accumulation of CD11C+, CD4+ and CD8+ cells in tumors, indicating that ECI301 augmented tumor-specific immune responses through CCR1-mediated DC accumulation in tumor (74). Here, CD8A is linked to neoplasm.